154 related articles for article (PubMed ID: 3592637)
1. Prospective malignancy grading and flow cytometry DNA distribution in biopsy specimens from invasive squamous cell carcinoma of the uterine cervix.
Willén R; Tropé C; Långström E; Ranstam J; Killander D; Clase L
Anticancer Res; 1987; 7(2):235-42. PubMed ID: 3592637
[TBL] [Abstract][Full Text] [Related]
2. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
[TBL] [Abstract][Full Text] [Related]
3. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
Lutgens LC; Schutte B; de Jong JM; Thunnissen FB
Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
[TBL] [Abstract][Full Text] [Related]
4. Prospective malignancy grading of invasive squamous carcinoma of the uterine cervix. Prognostic significance in a long-term follow-up.
Lindahl B; Ranstam J; Willén R
Anticancer Res; 2007; 27(4C):2829-32. PubMed ID: 17695455
[TBL] [Abstract][Full Text] [Related]
5. DNA aneuploidy in invasive carcinoma of the uterine cervix.
Kashyap V; Bhambhani S
Indian J Pathol Microbiol; 2000 Jul; 43(3):265-9. PubMed ID: 11218670
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry (FCM) of early radiation response in epidermoid carcinoma of uterine cervix.
Glasová M; Siracký J; Masák L; Kysela B
Neoplasma; 1992; 39(6):353-6. PubMed ID: 1491725
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell kinetics in elderly patients with cervical cancer.
Minagawa Y; Kigawa J; Kanamori Y; Itamochi H; Terakawa N
Obstet Gynecol; 1993 Apr; 81(4):610-4. PubMed ID: 7681554
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
11. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
[TBL] [Abstract][Full Text] [Related]
12. Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial.
Wolfson AH; Winter K; Crook W; Krishan A; Grigsby PW; Markoe AM; Morris M; Gaffney DK; Eifel PJ; Lucci JA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):111-7. PubMed ID: 17919835
[TBL] [Abstract][Full Text] [Related]
13. S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix.
Strang P; Eklund G; Stendahl U; Frankendal B
Anticancer Res; 1987; 7(4B):807-10. PubMed ID: 3674766
[TBL] [Abstract][Full Text] [Related]
14. Vulvar squamous carcinoma: prognostic role of DNA content.
Mariani L; Conti L; Atlante G; Sciarretta F; Pozzi M; Vercillo M; Francavilla V; De Franceschi L; Rossi S; Sindico R; Atlante M; Gandolfo GM
Gynecol Oncol; 1998 Nov; 71(2):159-64. PubMed ID: 9826454
[TBL] [Abstract][Full Text] [Related]
15. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
[TBL] [Abstract][Full Text] [Related]
17. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
Singh M; Prasad S; Kalra N; Singh U; Shukla Y
Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
[TBL] [Abstract][Full Text] [Related]
18. [DNA flow cytometry: perspective prognostic parameters in carcinoma of the uterine cervix].
Anton M; Nenutil R; Kopecný J; Rejthar A; Zaloudík J; Hausner P; Ptácková B
Cesk Gynekol; 1992 Apr; 57(2):49-55. PubMed ID: 1628337
[TBL] [Abstract][Full Text] [Related]
19. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
